|
BTAF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65989444411707E-12 |
| Normal-vs-Stage2 |
2.93039999998967E-06 |
| Normal-vs-Stage3 |
2.60999999945888E-07 |
| Normal-vs-Stage4 |
1.62161999999189E-05 |
| Stage1-vs-Stage2 |
3.764200E-01 |
| Stage1-vs-Stage3 |
2.783200E-01 |
| Stage1-vs-Stage4 |
5.402000E-01 |
| Stage2-vs-Stage3 |
1.197450E-01 |
| Stage2-vs-Stage4 |
2.456600E-01 |
| Stage3-vs-Stage4 |
7.735400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.99840144432528E-15 |
| Normal-vs-AfricanAmerican |
4.70750000003406E-06 |
| Normal-vs-Asian |
1.214090E-02 |
| Caucasian-vs-AfricanAmerican |
1.784400E-01 |
| Caucasian-vs-Asian |
2.507800E-01 |
| AfricanAmerican-vs-Asian |
6.150000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.96318525272454E-13 |
| Normal-vs-Female |
9.40358901857508E-14 |
| Male-vs-Female |
1.978810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.615960E-02 |
| Normal-vs-Age(41-60Yrs) |
1.64057656348859E-12 |
| Normal-vs-Age(61-80Yrs) |
9.1917584654766E-12 |
| Normal-vs-Age(81-100Yrs) |
2.565700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.611200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.413400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.678800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.118600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.501200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.332600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.260600E-03 |
| Normal-vs-Grade 2 |
1.62680979798324E-12 |
| Normal-vs-Grade 3 |
1.79519954457419E-10 |
| Normal-vs-Grade 4 |
9.975300E-04 |
| Grade 1-vs-Grade 2 |
1.246960E-01 |
| Grade 1-vs-Grade 3 |
1.445750E-02 |
| Grade 1-vs-Grade 4 |
7.000600E-03 |
| Grade 2-vs-Grade 3 |
5.342100E-02 |
| Grade 2-vs-Grade 4 |
1.976180E-02 |
| Grade 3-vs-Grade 4 |
2.744600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62658775337832E-12 |
| Normal-vs-ccB subtype |
7.78650000032854E-08 |
| ccA subtype-vs-ccB subtype |
1.552170E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.27879953690535E-13 |
| Normal-vs-N1 |
8.809900E-02 |
| N0-vs-N1 |
3.273800E-01 |
|
|
